# The ONE Study ATDC Trial

> **NCT02252055** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 11 (actual)

## Conditions studied

- Renal Failure, End Stage

## Interventions

- **BIOLOGICAL:** ATDC_Nantes

## Key facts

- **NCT ID:** NCT02252055
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-19
- **Primary completion:** 2018-11-14
- **Final completion:** 2018-11-14
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252055, "The ONE Study ATDC Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02252055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*